May 18 | Products
The stent material, cutting techniques, finishing
techniques, and inspection techniques are integral to a quality medical stent.
Careful customization is required with these processes...
|
May 18 | News
The surgical team at the Montreal Heart Institute (MHI)
achieved a North American surgical milestone on May 1st with a sutureless
aortic valve replacement through a thoracic incision just five centimetres
long. The two patients in their seventies who underwent this innovative...
|
May 18 | News
Boston
Scientific Corporation announces two-year results from the PLATINUM
Small Vessel study, demonstrating excellent safety and effectiveness outcomes
for the 2.25 mm PROMUS Element™ Everolimus-Eluting Platinum Chromium (PtCr)
Stent System...
|
May 15 | News
BiO2 Medical, Inc.
a Texas based medical device manufacturer with corporate offices in San
Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado,
announced today that it has received CE Mark approval for the Angel™ Catheter,
a Nitinol Inferior Vena Cava...
|
May 15 | News
As EuroPCR 2012 gets under way today, Medtronic, Inc.
announced that the Resolute Integrity Coronary Stent System has received
European regulatory approval for several new indications, making it the
drug-eluting stent (DES) with the broadest range of approved indications...
|
May 15 | News
Boston Scientific Corporation announces
results from the REPRISE I feasibility trial, which evaluated the acute safety
of the Lotus™ Aortic Valve System in patients with severe aortic valve disease.
The Lotus Aortic Valve System is the first transcatheter aortic valve
replacement...
|
May 15 | News
Increased focus on providing optimum patient care in the
most cost efficient way is fuelling demand for intelligent infusion devices
termed “Smart Pumps.” A report from InMedica, a division of IMS Research (recently
acquired by IHS Inc.), on the global market...
|
May 14 | News
A robotic system can
safely assist interventional cardiologists in performing percutaneous coronary
interventions (PCI) while significantly reducing the physician's exposure to
radiation and improving precision and control, according to results of the
PRECISE study...
|
May 14 | News
Boston Scientific Corporation announces results
from the ASA Plavix (ASAP) Study, which studied the WATCHMAN® Left Atrial
Appendage Closure (LAAC) device. The data showed a reduction in the risk of
ischemic stroke by 75 percent in patients with atrial fibrillation...
|
May 10 | News
Interrad Medical, Inc.
a privately held medical device company, announced today that it has received
FDA clearance for four new sizes of the SecurAcath subcutaneous catheter
securement device. In response to requests from clinicians throughout the US, Canada
and Europe...
|
May 10 | News
Sorin Group, a global medical device
company and a leader in the treatment of cardiovascular diseases, announced
today at Heart Rhythm 2012, the Heart Rhythm Society’s 33rd Annual Scientific
Sessions, FDA approval and commercial launch for a full portfolio of pacing...
|
May 10 | News
Japan's leading diversified materials manufacturer, Nitto Denko Corporation, today announced that a basic
patent regarding the company's epoch-making antifibrotic therapy has been
successfully registered in the USA. Nitto Denko has been developing antifibrotic drugs...
|
May 10 | News
Biosense Webster, Inc.,
a worldwide leader in the diagnosis and treatment of cardiac arrhythmias,
announced the launch of the new THERMOCOOL® SF NAV irrigated ablation catheter
with Curve Visualization in the United
States.
|
May 4 | News
Sound
Interventions, Inc. today announced the successful completion of the company's
First-In-Human clinical trial to treat resistant hypertension.
The study was performed by Dr. Petr Neuzil and a team of
cardiologists at Holmolka Hospital in Prague,
Czech Republic.
|
May 4 | News
A research conducted at the University of Granada
has demonstrated the efficiency of a heart rehabilitation program aimed at
patients suffering from heart disease. The authors of this study affirm that it
is essential that heart rehabilitation programs aimed at cardiac patients...
|
May 4 | News
Topera Medical today
announced that its FDA-cleared RhythmView™ 3D mapping and diagnostic system
will be featured in 16 scientific presentations at the 33rd Annual Scientific
Sessions of the Heart Rhythm Society (HRS), May 9-12 in Boston.
|
May 3 | News
FORTRESST Dielectic Coating, ANCHORWIRET Transseptal Placement Guidewire and SMARTT Wire Technologies to Add to Company's Pipeline of Proprietary Technologies Targeted for Cardiac Rhythm Management MINNEAPOLIS--(BUSINESS WIRE)--May 3, 2012-- Lake Region Medical, a global development and...
|